
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
Justin J. Leitenberger, Cindy Berthelot, Kristel D. Polder, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 3, pp. 480-484
Closed Access | Times Cited: 43
Justin J. Leitenberger, Cindy Berthelot, Kristel D. Polder, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 3, pp. 480-484
Closed Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 177
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 177
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients
Fanny Julia, Tony Petrella, M. Beylot‐Barry, et al.
British Journal of Dermatology (2013) Vol. 169, Iss. 3, pp. 579-586
Closed Access | Times Cited: 173
Fanny Julia, Tony Petrella, M. Beylot‐Barry, et al.
British Journal of Dermatology (2013) Vol. 169, Iss. 3, pp. 579-586
Closed Access | Times Cited: 173
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
Stéphane Dalle, M. Beylot‐Barry, Martine Bagot, et al.
British Journal of Dermatology (2009) Vol. 162, Iss. 1, pp. 74-79
Closed Access | Times Cited: 155
Stéphane Dalle, M. Beylot‐Barry, Martine Bagot, et al.
British Journal of Dermatology (2009) Vol. 162, Iss. 1, pp. 74-79
Closed Access | Times Cited: 155
The effects of vitamin B on the immune/cytokine network and their involvement in depression
Kathleen Mikkelsen, Lily Stojanovska, Monica D. Prakash, et al.
Maturitas (2016) Vol. 96, pp. 58-71
Closed Access | Times Cited: 136
Kathleen Mikkelsen, Lily Stojanovska, Monica D. Prakash, et al.
Maturitas (2016) Vol. 96, pp. 58-71
Closed Access | Times Cited: 136
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 110
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 110
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Justin Taylor, Michael Haddadin, Vivek Upadhyay, et al.
Blood (2019) Vol. 134, Iss. 8, pp. 678-687
Open Access | Times Cited: 84
Justin Taylor, Michael Haddadin, Vivek Upadhyay, et al.
Blood (2019) Vol. 134, Iss. 8, pp. 678-687
Open Access | Times Cited: 84
Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
Wasif Riaz, Ling Zhang, Pedro Horna, et al.
Cancer Control (2014) Vol. 21, Iss. 4, pp. 279-289
Open Access | Times Cited: 81
Wasif Riaz, Ling Zhang, Pedro Horna, et al.
Cancer Control (2014) Vol. 21, Iss. 4, pp. 279-289
Open Access | Times Cited: 81
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot‐Delettre, Anne Roggy, Arthur E. Frankel, et al.
Haematologica (2014) Vol. 100, Iss. 2, pp. 223-230
Open Access | Times Cited: 61
Fanny Angelot‐Delettre, Anne Roggy, Arthur E. Frankel, et al.
Haematologica (2014) Vol. 100, Iss. 2, pp. 223-230
Open Access | Times Cited: 61
Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 46
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 46
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Blastic Plasmacytoid Dendritic Cell Neoplasm
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 35
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 35
The advances in therapy of blastic plasmacytoid dendritic cell neoplasm
Daniel Kerr, Lubomir Sokol
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 9, pp. 733-739
Closed Access | Times Cited: 22
Daniel Kerr, Lubomir Sokol
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 9, pp. 733-739
Closed Access | Times Cited: 22
Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents
Shunan Wang, Xingtong Wang, Mingsuo Liu, et al.
Annals of Hematology (2018) Vol. 97, Iss. 4, pp. 563-572
Closed Access | Times Cited: 21
Shunan Wang, Xingtong Wang, Mingsuo Liu, et al.
Annals of Hematology (2018) Vol. 97, Iss. 4, pp. 563-572
Closed Access | Times Cited: 21
Blastic Plasmacytoid Dendritic Cell Neoplasm
Jieping Chen, Jingying Zhou, Dabing Qin, et al.
Journal of Clinical Oncology (2010) Vol. 29, Iss. 2, pp. e27-e29
Open Access | Times Cited: 26
Jieping Chen, Jingying Zhou, Dabing Qin, et al.
Journal of Clinical Oncology (2010) Vol. 29, Iss. 2, pp. e27-e29
Open Access | Times Cited: 26
Imiquimod reactivation of lichen planus.
Erik Domingues, Keri C Chaney, Mark J. Scharf, et al.
PubMed (2012) Vol. 89, Iss. 6, pp. 276-7, 283
Closed Access | Times Cited: 22
Erik Domingues, Keri C Chaney, Mark J. Scharf, et al.
PubMed (2012) Vol. 89, Iss. 6, pp. 276-7, 283
Closed Access | Times Cited: 22
Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature.
Naoya Ishibashi, Toshiya Maebayashi, Takuya Aizawa, et al.
PubMed (2015) Vol. 8, Iss. 5, pp. 8204-9
Closed Access | Times Cited: 20
Naoya Ishibashi, Toshiya Maebayashi, Takuya Aizawa, et al.
PubMed (2015) Vol. 8, Iss. 5, pp. 8204-9
Closed Access | Times Cited: 20
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
Amy M. Trottier, Sonia Cerquozzi, Carolyn Owen
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 85-93
Open Access | Times Cited: 17
Amy M. Trottier, Sonia Cerquozzi, Carolyn Owen
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 85-93
Open Access | Times Cited: 17
Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm
Michael Haddadin, Justin Taylor
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 539-552
Closed Access | Times Cited: 15
Michael Haddadin, Justin Taylor
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 539-552
Closed Access | Times Cited: 15
Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment
Jacques Fontaine, L. Thomas, B. Balme, et al.
Clinical and Experimental Dermatology (2009) Vol. 34, Iss. 5, pp. e43-e45
Closed Access | Times Cited: 20
Jacques Fontaine, L. Thomas, B. Balme, et al.
Clinical and Experimental Dermatology (2009) Vol. 34, Iss. 5, pp. e43-e45
Closed Access | Times Cited: 20
Gut-Associated Plasmacytoid Dendritic Cells Display an Immature Phenotype and Upregulated Granzyme B in Subjects with HIV/AIDS
Sergei Boichuk, Svetlana F. Khaiboullina, Bulat R. Ramazanov, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 14
Sergei Boichuk, Svetlana F. Khaiboullina, Bulat R. Ramazanov, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 14
A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Initially Mimicking Cutaneous Lupus Erythematosus
Hye Jung Chang, Myung Dong Lee, Hyeon Gyu Yi, et al.
Cancer Research and Treatment (2010) Vol. 42, Iss. 4, pp. 239-239
Open Access | Times Cited: 16
Hye Jung Chang, Myung Dong Lee, Hyeon Gyu Yi, et al.
Cancer Research and Treatment (2010) Vol. 42, Iss. 4, pp. 239-239
Open Access | Times Cited: 16
Blastic Plasmacytoid Dendritic Cell Neoplasm
Shweta Gera, Mhair Dekmezian, Madeleine Duvic, et al.
American Journal of Dermatopathology (2013) Vol. 36, Iss. 3, pp. 244-251
Closed Access | Times Cited: 13
Shweta Gera, Mhair Dekmezian, Madeleine Duvic, et al.
American Journal of Dermatopathology (2013) Vol. 36, Iss. 3, pp. 244-251
Closed Access | Times Cited: 13
Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm
Yumeng Zhang, Lubomir Sokol
Cancer Management and Research (2022) Vol. Volume 14, pp. 2107-2117
Open Access | Times Cited: 7
Yumeng Zhang, Lubomir Sokol
Cancer Management and Research (2022) Vol. Volume 14, pp. 2107-2117
Open Access | Times Cited: 7
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate
Shuku Sato, Eri Tanaka, Yotaro Tamai
Annals of Hematology (2019) Vol. 98, Iss. 3, pp. 801-803
Closed Access | Times Cited: 10
Shuku Sato, Eri Tanaka, Yotaro Tamai
Annals of Hematology (2019) Vol. 98, Iss. 3, pp. 801-803
Closed Access | Times Cited: 10